Výsledky vyhledávání

Management of acute atrial fibrillation in the intensive care unit: An international survey

Autor: Wetterslev, Mik, Møller, Morten Hylander, Granholm, Anders, Hassager, Christian, Haase, Nicolai, Aslam, Tayyba Naz, Shen, Jiawei, Young, Paul J., Aneman, Anders, Hästbacka, Johanna, Siegemund, Martin, Cronhjort, Maria, Lindqvist, Elin, Myatra, Sheila N., Kalvit, Kushal, Arabi, Yaseen M., Szczeklik, Wojciech, Sigurdsson, Martin I., Balik, Martin, Keus, Frederik, Perner, Anders, Huang, Bin, Yan, Miao, Liu, Wei, Deng, Yanjiu, Zhang, Lei, Suk, Pavel, Mørk Sørensen, Kasper, Andreasen, Anne Sofie, Bestle, Morten H., Krag, Mette, Poulsen, Lone M., Hildebrandt, Thomas, Møller, Kirsten, Møller-Sørensen, Hasse, Bove, Jeppe, Kilsgaard, Toke A., Salam, Idrees Ahmad, Brøchner, Anne Craveiro, Strøm, Thomas, Sølling, Christoffer, Kolstrup, Line, Boczan, Mariusz, Rasmussen, Bodil S., Darfelt, Iben S., Jalkanen, Ville, Lehto, Pasi, Reinikainen, Matti, Kárason, Sigurbergur, Sigvaldason, Kristinn

Publikováno v: Acta Anaesthesiologica Scandinavica, 66(3), 375-385. Wiley
Wetterslev, M, Møller, M H, Granholm, A, Hassager, C, Haase, N, Aslam, T N, Shen, J, Young, P J, Aneman, A, Hästbacka, J, Siegemund, M, Cronhjort, M, Lindqvist, E, Myatra, S N, Kalvit, K, Arabi, Y M, Szczeklik, W, Sigurdsson, M I, Balik, M, Keus, F, Perner, A, Huang, B, Yan, M, Liu, W, Deng, Y, Zhang, L, Suk, P, Mørk Sørensen, K, Andreasen, A S, Bestle, M H, Krag, M, Poulsen, L M, Hildebrandt, T, Møller, K, Møller-Sørensen, H, Bove, J, Kilsgaard, T A, Salam, I A, Brøchner, A C, Strøm, T, Sølling, C, Kolstrup, L, Boczan, M, Rasmussen, B S, Darfelt, I S, Jalkanen, V, Lehto, P, Reinikainen, M, Kárason, S, Sigvaldason, K & the AFIB-ICU collaborators 2021, ' Management of acute atrial fibrillation in the intensive care unit : An international survey ', Acta Anaesthesiologica Scandinavica, vol. 66, no. 3, pp. 375-385 . https://doi.org/10.1111/aas.14007

Background: Atrial fibrillation (AF) is common in intensive care unit (ICU) patients and is associated with poor outcomes. Different management strategies exist, but the evidence is limited and derived from non-ICU patients. This international survey

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94b37440e58ab875598bc78e8702df93
https://research.rug.nl/en/publications/4308d6fd-a537-43cd-bf85-9cb361501238

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Dietary K + acts as a genuine diuretic

Autor: Samuel L. Svendsen, Simon Kornvig, Peder Berg, Iben S. Jensen, Isabela B. B. A. de Araujo, Casper K. Larsen, Jens Leipziger, Mads V. Sørensen

Publikováno v: Svendsen, S L S C, Kornvig, S, Berg, P, Jensen, I S, Bastos Binotti Abreu De Araujo, I, Larsen, C K, Leipziger, J G & Sørensen, M V 2022, ' Dietary K + acts as a genuine diuretic ', Acta Physiologica (Online) . https://doi.org/10.1111/apha.13762
Svendsen, S L, Kornvig, S, Berg, P, Jensen, I S, de Araujo, I B B A, Larsen, C K, Leipziger, J & Sorensen, M V 2022, ' Dietary K + acts as a genuine diuretic ', Acta Physiologica, vol. 234, no. 2, e13762 . https://doi.org/10.1111/apha.13762

K+ balance in mammals relies on regulated renal K+ excretion matching unregulated fluctuating K+ intake. Upon a K+ rich meal, rapid and powerful K+ excretion is needed. Renal K+ secretion is stimulated by increased tubular flow. We speculated that hi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98d5ac85159b7324c33842d294ad8b83
https://pure.au.dk/portal/da/publications/dietary-k--acts-as-a-genuine-diuretic(041f0e85-4519-44ea-9794-a076b6f89fc5).html

Zobrazit plný text záznamu

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

Autor: Anders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, Sheila Nainan Myatra, Bharath Kumar Tirupakuzhi Vijayaraghavan, Maria Cronhjort, Rebecka Rubenson Wahlin, Stephan M. Jakob, Luca Cioccari, Gitte Kingo Vesterlund, Tine Sylvest Meyhoff, Marie Helleberg, Morten Hylander Møller, Thomas Benfield, Balasubramanian Venkatesh, Naomi E. Hammond, Sharon Micallef, Abhinav Bassi, Oommen John, Vivekanand Jha, Klaus Tjelle Kristiansen, Charlotte Suppli Ulrik, Vibeke Lind Jørgensen, Margit Smitt, Morten H. Bestle, Anne Sofie Andreasen, Lone Musaeus Poulsen, Bodil Steen Rasmussen, Anne Craveiro Brøchner, Thomas Strøm, Anders Møller, Mohd Saif Khan, Ajay Padmanaban, Jigeeshu Vasishtha Divatia, Sanjith Saseedharan, Kapil Borawake, Farhad Kapadia, Subhal Dixit, Rajesh Chawla, Urvi Shukla, Pravin Amin, Michelle S. Chew, Christian Aage Wamberg, Neeta Bose, Mehul S. Shah, Iben S. Darfelt, Christian Gluud, Theis Lange, Anders Perner

Publikováno v: Granholm, A, Kjær, M-B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Møller, A, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580–589 . https://doi.org/10.1007/s00134-022-06677-2
Granholm, A, Kjær, M B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Møller, A, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580-589 . https://doi.org/10.1007/s00134-022-06677-2
Granholm, A, Kjær, M-B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580-589 . https://doi.org/10.1007/s00134-022-06677-2

PURPOSE: We assessed long-term outcomes of dexamethasone 12 mg versus 6 mg given daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe hypoxaemia.METHODS: We assessed 180-day mortality and health-related quality of l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a03aca1ede6095b26a7bc6659898e2a

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Dietary K

Autor: Samuel L, Svendsen, Simon, Kornvig, Peder, Berg, Iben S, Jensen, Isabela B B A, de Araujo, Casper K, Larsen, Jens, Leipziger, Mads V, Sørensen

Publikováno v: Acta physiologica (Oxford, England)REFERENCES. 234(2)

KMice were K(1) Mice switched from a 1% to 2% KDietary K

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a188f3434ef12d794058e0371b7d8d47
https://pubmed.ncbi.nlm.nih.gov/34984847

Zobrazit plný text záznamu

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia:The COVID STEROID 2 Randomized Trial

Autor: Munch, Marie W, Myatra, Sheila N, Vijayaraghavan, Bharath Kumar Tirupakuzhi, Saseedharan, Sanjith, Benfield, Thomas, Wahlin, Rebecka R, Rasmussen, Bodil S, Andreasen, Anne Sofie, Poulsen, Lone M, Cioccari, Luca, Khan, Mohd S, Kapadia, Farhad, Divatia, Jigeeshu V, Br��chner, Anne C, Bestle, Morten H, Helleberg, Marie, Michelsen, Jens, Padmanaban, Ajay, Bose, Neeta, M��ller, Anders, Borawake, Kapil, Kristiansen, Klaus T, Shukla, Urvi, Chew, Michelle S, Dixit, Subhal, Ulrik, Charlotte S, Amin, Pravin R, Chawla, Rajesh, Wamberg, Christian A, Shah, Mehul S, Darfelt, Iben S, J��rgensen, Vibeke L, Smitt, Margit, Granholm, Anders, Kj��r, Maj-Brit N, M��ller, Morten H, Meyhoff, Tine S, Vesterlund, Gitte K, Hammond, Naomi E, Micallef, Sharon, Bassi, Abhinav, John, Oommen, Jha, Anubhuti, Cronhjort, Maria, Jakob, Stephan M, Gluud, Christian, Lange, Theis, Kadam, Vaijayanti, Marcussen, Klaus V, Hollenberg, Jacob, Hedman, Anders, Nielsen, Henrik, Schj��rring, Olav L, Jensen, Marie Q, Leistner, Jens W, Jonassen, Trine B, Kristensen, Camilla M, Clapp, Esben C, Hjorts��, Carl J S, Jensen, Thomas S, Halstad, Liv S, Bak, Emilie R B, Zaabalawi, Reem, Metcalf-Clausen, Matias, Abdi, Suhayb, Hatley, Emma V, Aksnes, Tobias S, Gleipner-Andersen, Emil, Alarc��n, Arif F, Yamin, Gabriel, Heymowski, Adam, Berggren, Anton, La Cour, Kirstine, Weihe, Sarah, Pind, Alison H, Engstr��m, Janus, Jha, Vivekanand, Venkatesh, Balasubramanian, Perner, Anders

Publikováno v: COVID STEROID 2 Trial Group, Rasmussen, B S, Nielsen, H & Schjørring, O L 2021, ' Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia : The COVID STEROID 2 Randomized Trial ', JAMA: The Journal of the American Medical Association, vol. 326, no. 18, pp. 1807-1817 . https://doi.org/10.1001/jama.2021.18295
Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Saseedharan, S, Benfield, T, Wahlin, R R, Rasmussen, B S, Andreasen, A S, Poulsen, L M, Cioccari, L, Khan, M S, Kapadia, F, Divatia, J V, Brochner, A C, Bestle, M H, Helleberg, M, Michelsen, J, Padmanaban, A, Bose, N, Møller, A, Borawake, K, Kristiansen, K T, Shukla, U, Chew, M S, Dixit, S, Ulrik, C S, Amin, P R, Chawla, R, Wamberg, C A, Shah, M S, Darfelt, I S, Jorgensen, V L, Smitt, M, Granholm, A, Kjær, M-B N, Møller, M H, Meyhoff, T S, Vesterlund, G K, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, A, Cronhjort, M, Jakob, S M, Gluud, C, Lange, T, Kadam, V, Marcussen, K V, Hollenberg, J, Hedman, A, Nielsen, H, Schjorring, O L, Jensen, M Q, Leistner, J W, Jonassen, T B, Kristensen, C M, Clapp, E C, Hjortso, C J S, Jensen, T S, Halstad, L S, Bak, E R B, Zaabalawi, R, Metcalf-Clausen, M, Abdi, S, Hatley, E V, Aksnes, T S, Gleipner-Andersen, E, Alarcon, A F, Yamin, G, Heymowski, A, Berggren, A, La Cour, K, Weihe, S, Pind, A H, Engstrom, J, Jha, V, Venkatesh, B & Perner, A 2021, ' Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia The COVID STEROID 2 Randomized Trial ', J A M A: The Journal of the American Medical Association, vol. 326, no. 18, pp. 1807-1817 . https://doi.org/10.1001/jama.2021.18295
COVID STEROID 2 Trial Group 2021, ' Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia : The COVID STEROID 2 Randomized Trial ', JAMA: The Journal of the American Medical Association, vol. 326, no. 18, pp. 1807-1817 . https://doi.org/10.1001/jama.2021.18295
The COVID STEROID 2 Trial Group 2021, ' Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive without Life Support in Adults with COVID-19 and Severe Hypoxemia : The COVID STEROID 2 Randomized Trial ', JAMA-Journal of the American Medical Association, vol. 326, no. 18, pp. 1807-1817 . https://doi.org/10.1001/jama.2021.18295

Importance A daily dose with 6 mg of dexamethasone is recommended for up to 10 days in patients with severe and critical COVID-19, but a higher dose may benefit those with more severe disease. Objective To assess the effects of 12 mg/d vs 6 mg/d of d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3adc4ced93a6a128adc2824e55d4fc00
https://vbn.aau.dk/da/publications/04a329c2-9c2e-411e-8d5b-9bf36f405df6

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání